Home › Funds › BRAIDWELL LP › MAZE
BRAIDWELL LP position in MAZE
MAZE THERAPEUTICS INC COM · Health Care
BRAIDWELL LP reported holding 1,140,040 shares of MAZE (MAZE THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$34.0M, representing 1.34% of its reported portfolio and ranking #27 among its reported holdings. BRAIDWELL LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BRAIDWELL LP's MAZE position evolved
BRAIDWELL LP first disclosed a stake in MAZE in Q2 2026 at 1,140,040 shares (US$34.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.14M | $34.02M | New |
About MAZE and 13F data
MAZE (MAZE THERAPEUTICS INC COM) is a Health Care company. 74 other funds we track also report a position in MAZE — the largest reported positions include Frazier Life Sciences Management, L.P. (US$150.2M), TRV GP IV, LLC (US$133.5M), ARCH Venture Management, LLC (US$123.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MAZE
- Frazier Life Sciences Management, L.P. 5.03M sh · $150.18M · Q2 2026
- TRV GP IV, LLC 4.47M sh · $133.50M · Q2 2026
- ARCH Venture Management, LLC 4.12M sh · $122.98M · Q2 2026
- Deep Track Capital, LP 3.73M sh · $111.38M · Q2 2026
- Logos Global Management LP 1.94M sh · $57.74M · Q2 2026
- a16z Capital Management, L.L.C. 1.70M sh · $50.79M · Q2 2026
- Venrock Adviser, LLC 1.60M sh · $47.80M · Q2 2026
- Alphabet Inc. 1.39M sh · $41.44M · Q2 2026
- Farallon Capital Management 1.11M sh · $33.06M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.11M sh · $33.06M · Q2 2026
- General Catalyst Group Management, LLC 1.04M sh · $30.91M · Q2 2026
- TRV GP V, LLC 950.80K sh · $28.37M · Q2 2026
FAQ
How long has BRAIDWELL LP held MAZE?
BRAIDWELL LP has disclosed MAZE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is BRAIDWELL LP's current position in MAZE?
As of Q2 2026, BRAIDWELL LP holds 1.14M shares of MAZE (MAZE THERAPEUTICS INC COM), valued at $34.02M, representing 1.34% of its reported portfolio and ranking #27.
Has BRAIDWELL LP been buying or selling MAZE?
In the latest 13F filing (Q2 2026), BRAIDWELL LP newly opened its position in MAZE.
Which other funds hold MAZE?
Other major institutional holders of MAZE include Frazier Life Sciences Management, L.P., TRV GP IV, LLC, ARCH Venture Management, LLC, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.